1 December 2022

Last updated: Tuesday 29 November 2022

Research Directory

Microbiome-based therapies as anti-cancer agents

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

The race to develop a COVID-19 vaccine

Coronavirus pandemic ushers in new collaborations

Meeting the challenge of viral vector manufacture

Oxford BioMedica perfects lentiviral vectors for gene therapy